We develop and perform proprietary gene expression profiling AI-based molecular classifiers tests in Oncology.
We are Latin America leaders on Thyroid molecular tests with our very own family of mir-THYpe tests.
The mir-THYpe full is a molecular test for indeterminate thyroid nodules which has already impacted more than 7.000 patients in Latam and can reduce up to 75% of unnecessary surgeries, making our affordable test a cost effective option to health systems.
Science, Evidence & True Impact.
Company Details
- Employees
- 43
- Founded
- 2015
- Address
- Rua Florêncio De Abreu, 1945, Ribeirão Preto,são Paulo 14015-060,brazil
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Website
- onkos.com.br
- HQ
- Ribeirão Preto, São Paulo
Onkos Molecular Diagnostics Questions
Onkos Molecular Diagnostics's website is onkos.com.br
Onkos Molecular Diagnostics's LinkedIn profile is https://br.linkedin.com/company/onkos-diagnosticos-moleculares
Onkos Molecular Diagnostics has
43 employees.
View email and phone details for 43
employees at Onkos Molecular Diagnostics.
Onkos Molecular Diagnostics's industry is
Medical and Diagnostic Laboratories
Onkos Molecular Diagnostics's top competitors are
Genera,
Supera Park,
Vitrolife & Igenomix Brasil, Part Of Vitrolife Group,
Yosen,
Lychnoflora,
Elevescience Pesquisa E Desenvolvimento,
Carefy,
Dglab Dna Tests,
Onkos Surgical,
Bymycell - Genômica Simplificada.
Onkos Molecular Diagnostics's categories are Medical and Diagnostic Laboratories
Onkos Molecular Diagnostics's founding year is 2015
